A practical reference on Thymalfasin: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-05 and is reviewed periodically as new material appears.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈3,108 Da | Synthetic 28-residue peptide |
| Amino acid count | 28 | N-terminal serine carries an acetyl group |
| Appearance | White to off-white powder | Lyophilized solid |
| Water solubility | Freely soluble | Dissolves in aqueous buffer |
| Common synonyms | Thymalfasin; Tα1 | Thymalfasin is the international nonproprietary name |
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Collagen alpha-5(IV) chain is a protein that in humans is encoded by the COL4A5 gene. This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Three transcript variants have been identified for this gene.
Collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital), also known as COL2A1, is a human gene that provides instructions for the production of the pro-alpha1(II) chain of type II collagen.
== Company structure == Corporate group, an industrial business group in Western democracies Combine (enterprise), an industrial business group in socialist countries, particularly the former Soviet Union
== Contraindications == Pioglitazone/metformin is contraindicated in people with known hypersensitivity to any components of this combination. These combination also contraindicated in renal disease which may also result from conditions, e.g., acute myocardial infarction, sepsis, acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.
Sources: en.wikipedia.org
== Capability Areas == In the context of Public Health Laboratories, the Association of Public Health Laboratories has identified 19 areas for self-assessment of laboratory informatics in their Laboratories Efficiencies Initiative. These include the following Capability Areas.
studied the effects of CREB and dynorphin on learned helplessness (an animal model for depression) in mice. Overexpression of dominant negative CREB (mCREB) in transgenic mice had an antidepressant effect (in terms of behavior), whereas overexpressing wild-type CREB caused an increase in depression-like symptoms. As described previously, CREB increases transcription of prodynorphin, which gives rise to different dynorphin subtypes. Newton et al. supported this mechanism, as the mCREB was colocalized with decreased expression of prodynorphin. Also, direct antagonism of dynorphin caused antidepressant-like effects similar to those seen with mCREB expression. Thus, the CREB-dynorphin pathway regulates mood as well as cocaine rewards. Shirayama et al. used several animal depression models in rats to describe the effects of dynorphins A and B in depression. The authors found that learned helplessness increases the levels of dynorphins A and B in the hippocampus and nucleus accumbens and that injecting KOR antagonist nor-BNI induces recovery from learned helplessness. Immobilization stress causes increases in the levels of both dynorphins A and B in the hippocampus and nucleus accumbens. Forced swim stress increases the levels of dynorphin A in the hippocampus. Shirayama et al. concluded that both dynorphins A and B were important in stress response. The authors proposed several mechanisms to account for the effects of the KOR antagonist norBNI on learned helplessness.
== Lineage Foundation for Good == In October 2021, Lineage announced the launch of Lineage Foundation for Good, the independent philanthropic arm of Lineage. The Foundation was created by a $3 million gift from Lineage to support the company's philanthropic efforts and support initiatives and organizations that align to its mission and work towards innovative and sustainable solutions to help reduce food waste and fight food insecurity. In 2022, Lineage facilitated donations of over 2.7 million pounds of food products from customers, issued almost $3 million in grants, and recorded over 5,000 volunteer hours via the Lineage Foundation for Good during its first year as a public charity. The same year, Lineage Hardship Fund launched to provide assistance to team members impacted by hardships, providing over $622,000 in 2022 to support 152 team members and their families through the Lineage Foundation for Good. The Foundation has partnered with organizations including Feeding America and Global FoodBanking Network to help provide meals to those in need. In 2023, Lineage and the Foundation sponsored DC Central Kitchen's Capital Food Fight and partnered with Forgotten Harvest to supply nearly 12,000 metro Detroit households with holiday meal boxes. Also in 2023, the Foundation announced a new partnership with Jared Goff, quarterback for the Detroit Lions and global ambassador for the Foundation, to donate meals for every touchdown the quarterback threw and to provide meals to families in need during the holidays.
Bemethyl, also commonly referred to in literature as bemitil, is an actoprotector drug which is also antihypoxant (combating conditions of hypoxia), antioxidant, and antimutagenic. Bemethyl is primarily classified as an actoprotector: a synthetic adaptogen with significant capacity to increase physical performance. It is approved for use in Ukraine as a dietary supplement. Bemethyl is commonly used in preparing for international competitions by Ukrainian national sport teams. Bemethyl is formulated as a hydrobromide salt. Its parent compound is 2-ethylsulfanyl-1H-benzimidazole.
===== Penis ===== In 2020, researchers developed a method for tissue repair of male genitals through the use of a bioink they designed. This bioink would include stem cells along with the ink itself to increase its compatibility with the body and its ability to heal. A hydrogel scaffold was printed using a 3D print-ultraviolet photo crosslinking strategy, which is similar in concept to an SLA printer. Their design was able to successfully be integrated the corpus cavernosum of a rabbit's penis. This printed structure was able to return functionality to the organ and increase its fertility. While not tested or created using human cells, further efforts are being conducted to improve this field.
Sources: en.wikipedia.org
Brenner's work includes the first human trial of NR, which demonstrated safe oral availability as an NAD+ precursor. His work characterized ways in which the NAD system is disrupted by diseases and conditions of metabolic stress. Further, he identified a specific mechanism by which citrin deficiency results in sweet aversion and metabolic dysfunction-associated steatotic liver disease (MASLD), and identified glycerol-3-phosphate as the activator of carbohydrate response element binding protein (ChREBP).
Integral membrane proteins are permanently attached to the membrane. Such proteins can be separated from the biological membranes only using detergents, nonpolar solvents, or sometimes denaturing agents. They can be classified according to their relationship with the bilayer:
4 Cytc2+ + O2 + 8H+inside → 4 Cytc3+ + 2 H2O + 4H+outside Although the heme proteins are the most important class of iron-containing proteins, the iron–sulfur proteins are also very important, being involved in electron transfer, which is possible since iron can exist stably in either the +2 or +3 oxidation states. These have one, two, four, or eight iron atoms that are each approximately tetrahedrally coordinated to four sulfur atoms; because of this tetrahedral coordination, they always have high-spin iron. The simplest of such compounds is rubredoxin, which has only one iron atom coordinated to four sulfur atoms from cysteine residues in the surrounding peptide chains. Another important class of iron–sulfur proteins is the ferredoxins, which have multiple iron atoms. Transferrin does not belong to either of these classes. The ability of sea mussels to maintain their grip on rocks in the ocean is facilitated by their use of organometallic iron-based bonds in their protein-rich cuticles. Based on synthetic replicas, the presence of iron in these structures increased elastic modulus 770 times, tensile strength 58 times, and toughness 92 times. The amount of stress required to permanently damage them increased 76 times.
A complete cessation of the Jewish migration to Palestine. A total halt to the sale of land to Jews. Cancelation of the British Mandate in Palestine and the Balfour Declaration. Recognition of the right of Arabs to their land and recognition of the independence of Palestine as a sovereign state, like all other Arab states, with a promise to provide minority rights to the Jews according to the rules of democracy. The Arab states and the Arab Higher Committee officially boycotted the United Nations Special Committee on Palestine (UNSCOP) formed in May 1947 to investigate the cause of the conflict in Palestine, and, if possible, devise a solution. Despite the official Arab boycott, several Arab officials and intellectuals privately met UNSCOP members to argue for a unitary Arab-majority state, among them AHC member and former Jerusalem mayor Husayn al-Khalidi. UNSCOP also received written arguments from Arab advocates. The Arab Higher Committee rejected both the majority and minority recommendations within the UNSCOP report. They "concluded from a survey of Palestine history that Zionist claims to that country had no legal or moral basis". The Arab Higher Committee argued that only an Arab State in the whole of Palestine would be consistent with the UN Charter. The Arab Higher Committee as well as the Arab states were actively involved in the deliberations of the Ad Hoc Committee on the Palestinian Question, formed in October 1947, again repeating its previous demands.
==== Other ==== In the production of nodular graphite in cast iron. As an additive agent in conventional propellants. As a reducing agent to separate uranium and other metals from their salts. As a sacrificial (galvanic) anode to protect boats, underground tanks, pipelines, buried structures, and water heaters. Alloyed with zinc to produce the zinc sheet used in photoengraving plates in the printing industry, dry-cell battery walls, and roofing. Alloyed with aluminium with aluminium-magnesium alloys being used mainly for beverage cans, sports equipment such as golf clubs, fishing reels, and bows and arrows. Many car and aircraft manufacturers have made engine and body parts from magnesium. Magnesium batteries have been commercialized as primary batteries, and are an active topic of research for rechargeable batteries, such as magnesium sulfur batteries. In biodegradable magnesium implants.
Sources: en.wikipedia.org
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.
It is a 28-residue synthetic peptide studied as an immune-modulating agent and approved as a drug in some countries. The sequence matches a naturally occurring fragment isolated from thymus tissue. It is not a hormone in the endocrine sense.